Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anna Wolska-Washer, Pawel Robak, Piotr Smolewski & Tadeusz Robak. (2017) Emerging antibody-drug conjugates for treating lymphoid malignancies. Expert Opinion on Emerging Drugs 22:3, pages 259-273.
Read now
Read now
Yu-Yu Tien, Brian K. Link, John M. Brooks, Kara Wright & Elizabeth Chrischilles. (2015) Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile. Leukemia & Lymphoma 56:1, pages 65-71.
Read now
Read now
Xavier Thomas. (2014) Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 1-8.
Read now
Read now
Tadeusz Robak & Ewa Robak. (2014) Current Phase II antibody-drug conjugates for the treatment of lymphoid malignancies. Expert Opinion on Investigational Drugs 23:7, pages 911-924.
Read now
Read now
John R Adair, Philip W Howard, John A Hartley, David G Williams & Kerry A Chester. (2012) Antibody–drug conjugates – a perfect synergy. Expert Opinion on Biological Therapy 12:9, pages 1191-1206.
Read now
Read now
Xavier Thomas. (2012)
Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia. Expert Opinion on Investigational Drugs 21:6, pages 871-878.
Read now
Read now
Articles from other publishers (14)
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
Crossref
J.M. Redman, E.M. Hill, D. AlDeghaither & L.M. Weiner. (2015) Mechanisms of action of therapeutic antibodies for cancer. Molecular Immunology 67:2, pages 28-45.
Crossref
Crossref
Tadeusz Robak & Pawel Robak. 2015. Resistance to Immunotoxins in Cancer Therapy. Resistance to Immunotoxins in Cancer Therapy
89
128
.
Monika Podhorecka, Justyna Markowicz, Agnieszka Szymczyk & Johannes Pawlowski. (2014) Target Therapy in Hematological Malignances: New Monoclonal Antibodies. International Scholarly Research Notices 2014, pages 1-16.
Crossref
Crossref
Gladys S. Ingle & Suzie J. Scales. (2014) DropArray™, a Wall-Less 96-Well Plate for Uptake and Immunofluorescence Microscopy, Confirms CD22 Recycles. Traffic 15:3, pages 255-272.
Crossref
Crossref
Maurizio Martelli, Andrés J.M. Ferreri, Claudio Agostinelli, Alice Di Rocco, Michael Pfreundschuh & Stefano A. Pileri. (2013) Diffuse large B-cell lymphoma. Critical Reviews in Oncology/Hematology 87:2, pages 146-171.
Crossref
Crossref
Tadeusz Robak. (2013) Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia. Future Oncology 9:1, pages 69-91.
Crossref
Crossref
Birte Nolting. 2013. Antibody-Drug Conjugates. Antibody-Drug Conjugates
71
100
.
Ingrid Sassoon & Véronique Blanc. 2013. Antibody-Drug Conjugates. Antibody-Drug Conjugates
1
27
.
Tadeusz Robak. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma
191
212
.
Sima Jeha. 2013. Childhood Leukemias. Childhood Leukemias
616
631
.
Franco Dosio, Paola Brusa & Luigi Cattel. (2011) Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components. Toxins 3:7, pages 848-883.
Crossref
Crossref
Gopal Iyer, Fabien Pinaud, Jianmin Xu, Yuval Ebenstein, Jack Li, Jessica Chang, Maxime Dahan & Shimon Weiss. (2011) Aromatic Aldehyde and Hydrazine Activated Peptide Coated Quantum Dots for Easy Bioconjugation and Live Cell Imaging. Bioconjugate Chemistry 22:6, pages 1006-1011.
Crossref
Crossref
Saileta Prabhu, C Andrew Boswell, Douglas Leipold, Leslie A Khawli, Dongwei Li, Dan Lu, Frank-Peter Theil, Amita Joshi & Bert L Lum. (2011) Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacology. Therapeutic Delivery 2:6, pages 769-791.
Crossref
Crossref